Newspaper publication of Q1 FY27 unaudited financial results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Auro Laboratories has submitted newspaper clippings of its unaudited Q1 FY27 results (quarter ended June 30, 2026) published on August 15, 2026 in Mumbai Lakshdeep (Marathi) and Active Times Mumbai (English). Total income rose to Rs 887.64 lakh from Rs 319.07 lakh YoY. Net profit after tax was Rs 104.56 lakh versus a loss of Rs 10.55 lakh YoY. EPS stood at Rs 1.68 versus loss of Rs 0.17. Board approved results on August 14, 2026.
Routine SEBI compliance filing; Q1 numbers show strong YoY recovery with profit after tax of Rs 104.56 lakh against a loss last year.